CO 011: PRECLINICAL EVIDENCES OF P3 MAB IMMUNORESTORATION CAPACITY ON SUPPRESSED BALB/C MICE

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S6, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 011: PRECLINICAL EVIDENCES OF P3 MAB IMMUNORESTORATION CAPACITY ON SUPPRESSED BALB/C MICE Martínez D, Rodríguez-Zhurbenko N, Griñan T, Rondón T, Vázquez AM, Hernández AM. Center of Molecular Immunology, Havana, Cuba. E-mail:darel@cim.sld.cu Abstract Introduction: A fast … Continue reading CO 011: PRECLINICAL EVIDENCES OF P3 MAB IMMUNORESTORATION CAPACITY ON SUPPRESSED BALB/C MICE

J Pharm Pharmacogn Res 2(Suppl. 1): S6, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 011: PRECLINICAL EVIDENCES OF P3 MAB IMMUNORESTORATION CAPACITY ON SUPPRESSED BALB/C MICE

Martínez D, Rodríguez-Zhurbenko N, Griñan T, Rondón T, Vázquez AM, Hernández AM.

Center of Molecular Immunology, Havana, Cuba.
Abstract

Introduction: A fast reconstitution of T cell dependent immunity is a critical issue for patients treated with lymphodepleting regimens. Prolonged period of T cell dysfunction may have serious consequences for the patients, like higher susceptibility to infections, reduced response to vaccines and easier tumor relapse. P3, a murine IgM mAb, recognize N-glycolilated gangliosides, sulphatides and antigens expressed in several human tumors. This antibody has the ability to trigger an IgG antibody response in the syngeneic Balb/c model, even when it is administered without adjuvant or carrier protein. Although the mechanism by which the P3 activates the immune system is unknown, previous experiments show that it is capable of stimulate T cells populations.

Material and methods: We evaluate the importance of T cell populations in the P3 mAb immunogenicity and the capacity of P3 to recover T cells populations on immunosuppressed Balb/c mice, due to tumor or cyclophosphamide treatment.

Results: We show that the high immunogenicity of P3 mAb depends not only on CD4+ but also on CD8+ T cells, since the depletion of CD8+ or CD4+ T cells led to the loss of P3 mAb immunogenicity in the syngeneic model. Furthermore, the immunization with P3 mAb enhanced the recovery of the CD8+ T cell population in mice treated with an anti-CD8a antibody. Additionally, the immunization with P3 mAb restored the capacity of immunosuppressed mice to reject allogeneic tumors, a mechanism mediated by the action of CD8+ T cells. Finally, in mice with cyclophosphamide induced lymphopenia, the administration of P3 mAb accelerated the recovery of both CD4+ and CD8+ T cells.

Conclusions: These results show new possibilities for B and CD8+ T cells interactions during the immune response elicited by a self-protein. Furthermore they point to P3 mAb as a potential interesting candidate for the treatment of immunosuppressed patients.

Alendronate and platelet-rich plasma in sheep anterior cruciate ligament
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 526-538, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1845_12.3.526 Original Article Effect of alendronate and platelet-rich plasma in tendon-bones integration in sheep anterior cruciate ligament surgery [Efecto del alendronato y del plasma rico en plaquetas en la integración tendón-hueso en la cirugía del ligamento cruzado anterior ovino] Tangkas Sibarani1*, Bambang … Continue reading Alendronate and platelet-rich plasma in sheep anterior cruciate ligament
Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 514-525, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1739_12.3.514 Original Article Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2 [Potencial antiviral de complejos de selenio de Brassicaceae mediante la inhibición de la unión proteica entre MAP4 y la espiga de … Continue reading Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein
Andrographis paniculata and cardiovascular diseases
J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 487-513, May-Jun 2024. DOI: https://doi.org/10.56499/jppres23.1841_12.3.487 Review Andrographis paniculata: A potential supplementary therapy for cardiovascular diseases - A systematic review of its effects and molecular actions [Andrographis paniculata: Una terapia suplementaria potencial para las enfermedades cardiovasculares - Una revisión sistemática de sus efectos y acciones moleculares] Oluebube … Continue reading Andrographis paniculata and cardiovascular diseases

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio